Onconetix Reverse Stock Split
Onconetix, Inc. implemented a one-for-ten (1:10) reverse stock split of its common stock effective November 6, 2026. The split reduced the number of outstanding shares from approximately 6.7 million to 670,000 to satisfy Nasdaq listing requirements. Trading commenced on a split-adjusted basis under the existing symbol 'ONCO' with a new CUSIP number.